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ABSTRACT
Chlorhexidine is a commonly used antiseptic and disinfectant in the health-care setting. 
Anaphylaxis to chlorhexidine is a rare but potentially life-threatening complication. 
Epidemiologic data suggest that the cases of chlorhexidine allergy appears to be increasing. 
In this article we report a life-threatening anaphylactic shock with cardiorespiratory 
arrest, during urethral catheterization due to chlorhexidine. The authors also performed 
a literature review of PubMed library of anaphylactic cases reports due to this antiseptic 
between 2014 and 2018, demonstrating the increase in the number of cases occurring 
worldwide and the importance of detailed anamnesis and appropriate diagnostic workup of 
allergic reactions to disinfectants.
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INTRODUCTION
Chlorhexidine is an antiseptic and disinfectant used against a broad of bacteria, viruses and 
fungi [1]. Since its introduction in 1954, it is used in the hospital settings for medical and 
surgical products and widely in over-the-counter products [1, 2]. Many health professionals 
are unaware of its presence in different products, so it is often a ‘hidden’ allergen.
The most common allergic reactions described to chlorhexidine are delayed reactions (type 
IV hypersensitivity), T cell mediated, and occur after exposure to the antiseptic for topical 
use. Contact dermatitis is the most frequent manifestation [2-4]. Immediate reactions (type I 
hypersensitivity), have also been reported, but much less frequently, and symptoms can range 
from urticaria to anaphylaxis with a risk of cardiorespiratory arrest and death [2-4].
It has not been described cross reactivity between chlorhexidine and other antiseptic agents [1].
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CASE REPORT
A 75-year-old male with hypertension receiving beta-blocker and bladder cancer underwent 
transurethral tumor resection in 2014. Surveillance postsurgical cystoscopy under local 
anesthesia was performed every 6 months. During the 2nd procedure he developed 
generalized cutaneous pruritus with no other symptoms with spontaneous resolution after 
one hour. This reaction was interpreted as allergy to cefoxitin and it was recommended to 
avoid 2nd generation cephalosporins.
Twenty minutes after the 4th cystoscopy, he developed generalized urticaria, oropharyngeal 
tightening, dyspnea, hypotension (75/40 mmHg) and loss of consciousness with 
cardiorespiratory arrest. Cardiopulmonary resuscitation was initiated immediately with 
endovenous administration of adrenaline (1 mg), clemastine (2 mg) and hydrocortisone 
(200 mg) and orotracheal intubation with invasive ventilation. The patient recovered over 
the next 2 hours and was extubated on the same day.
The patient was referred to the immunoallergology outpatient clinic and a complete workup 
was performed. Local disinfection and anesthesia were performed with iodopovidone 
(Betadine, Meda Manufacturing, Mérignac, France) and lidocaine + chlorhexidine gel 
(Optilube, Optimum Medical Ltd., Leeds, United Kingdom). Prophylactic antibiotic therapy 
was performed only in 2nd procedure (cefoxitin) and ortho-phthalaldehyde (Cidex, Medos 
International SARL, Le Locle, Switzerland) was not used as cystoscope disinfectant.
The allergologic investigation revealed negative skin prick test (SPT) to iodopovidone 
and latex, and negative cutaneous tests (standard concentration [5] to benzyl penicilloyl-
polylysine (PPL), minor determinant mixture (MDM), amoxicillin, penicillin, cefoxitin). 
Specific IgE (sIgE) available (latex, penicillin, amoxicillin) were negative. Provocation tests to 
lidocaine and cefoxitin were negative.
SPT to chlorhexidine (2%) was strongly positive (11 mm × 10 mm wheal), with a positive sIgE 
- 4 kU/L (normal value: <0.35 kU/L). Table 1 summarizes the allergologic workup.
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Table 1. Allergologic workup carried out in our immunoallergology outpatient clinic
Reagent Skin prick test Intradermal test  
(standard ENDA concentration) [5]




Iodopovidone Negative Not advised Not available Tolerated
Chlorhexidine Positive Not advised 4 kU/L Contraindicated
Local anesthetics
Lidocaine Negative Not advised Not available Negative (SC)
Antibiotics
PPL and MDM Negatives Negative - -
Amoxicillin Negative Negative Negative Not performed
Penicillin Negative Negative Negative Not performed
Cefaclor Negative Negative Negative Not performed
Cefoxitin Negative Negative Not available Negative (IV)
Cefazolin Negative Negative Not available Not performed
Cefuroxime Negative Negative Not available Not performed
Other
Latex Negative - Negative Tolerated
ENDA, European Network for Drug Allergy; RV, reference value; SC, subcutaneous; PPL, benzyl penicilloyl-polylysine; MDM, minor determinant mixture; IV, intravenous.
We also performed a basophil activation test (BAT) using chlorhexidine digluconate 20% 
(1062 mg/mL) at 0.05%, 0.005%, 0.005%, and 0.00005% [6]. The basophil population was 
identified as HLA-DR-CD123+ CD203c+ cells and activation by CD63 expression. BAT was 
positive at 0.005%, 0.0005%, and 0.00005% with activation of 5.02%, 8.58%, and 11.9% 
and stimulation index of 3.22, 5.5, and 7.63 respectively (Fig. 1).
The diagnosis of severe allergic reaction to chlorohexidine was confirmed. The patient was 
advised to avoid products containing chlorhexidine. Subsequent cystoscopy was uneventful 
using lidocaine gel as local anesthetic and iodopovidone as disinfectant. Moreover, he was 
informed to be aware of chlorhexidine as a component of over the counter products and the 
need to avoid them.
DISCUSSION
The first case of anaphylaxis to chlorhexidine has been reported in 1984 in Japan [1, 3]. 
Although rare, the number of clinical case reports of anaphylaxis (type I hypersensitivity) 
to this antiseptic is increasing. Odedra et al. [1] published that from 1994 to 2013, 65 
case reports of chlorhexidine-related anaphylaxis were diagnosed. The majority was 
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Fig. 1. Basophil activation test performed in whole blood. (A) Identification of basophil population in the lymphocyte-monocyte gate a SSC/CD203c+. (B) Flow 
cytometry dot plots of CD63 expression (%) on CD123+/HLA-DR-/CD203c+ cells. (C) Histogram showing the mean fluorescence intensity (MFI) median of CD203c 
expression. SI, stimulation index (ratio of stimulated/unstimulated basophils).
among surgical patients (urology and cardiothoracic) [6]. From 1984 to 2014, 36 cases of 
perioperative anaphylaxis to chlorhexidine were published [2].
Most reactions have been reported after application of chlorhexidine to damaged skin surfaces 
(wounds, burns, surgical incision); and to mucous membranes (urethra, eyes, nose) or after 
insertion of medical devices (central venous catheters, CVC) impregnated with chlorhexidine [4].
The prevalence of perioperative anaphylaxis range from 0.05%–2% and is increasing [2]. True 
incidence attributed to chlorhexidine is unknown, with several authors suggesting that is rare, but 
some studies referring incidences ranging from 5.5% to 8.8% [2]. Sharp et al. (Australia, 2016) 
[2] in a review to chlorhexidine-induced anaphylaxis in surgical patient (total of 68 anaphylactic 
reactions) showed that most frequent cases occur due to the presence of chlorhexidine in urinary 
catheter lubricant (n = 30 [44.12%]), CVC (n=24 [35.29%]) and topical solutions (n=11 [16.18%]).
It appears to occur more frequently in men with mean age of 58 years, previously reporting a 
mild cutaneous reaction on chlorhexidine exposure [1].
Patients rarely have history of atopic disease. The clinical presentation is variable. In 
most cases patients developed erythematous rash/urticarial at the time of reaction and 
hypotension, with some presenting cardiorespiratory arrest [1, 2]. Bronchospasm is rarely 
reported [1, 2]. Our patient was older than the mean presented, however the reaction 
occurred during a cystoscopy. This procedure and the severity of the symptoms were similar 
to the most commonly described.
To our knowledge, in the last five years (2014–2018), a total of 24 cases of chlorhexidine-
related anaphylaxis were published (Table 2). The male gender is the most affected (83%). 
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Table 2. Published cases of chlorhexidine-induced anaphylaxis between 2014–2018
Study Country No. of cases Sex Age (yr) SPT sIgE (<0.35 kU/L) BAT
Nakonechna et al., 2014 [7] United Kingdom 6 M 50 NR 30 NR
M 78 NR 2.3 NR
M 72 Pos 4.4 NR
M 73 Pos 3.3 NR
M 73 Pos 11.8 NR
M 60 Pos 0.69 NR
Weng et al., 2014 [8] China 2 M 48 Pos NR NR
F 34 Pos NR NR
Buergi et al., 2014 [9] Switzerland 1 M 45 Pos 6.1 NR
Odedra et al., 2015 [1] United Kingdom 1 M 62 Pos NR NR
Rutkowski et al., 2015 [10] United Kingdom 1 M 73 Pos 13.1 NR
Hong et al., 2015 [11] Singapore 1 M 66 Pos NR NR
Stewart et al., 2015 [12] Australia 1 M 60 Pos Pos NR
Chen et al., 2016 [13] United Kingdom 1 - - Pos NR NR
Wang et al., 2016 [14] Thailand 1 M 54 NR 7.21 NR
Teixeira de Abreu et al., 2017 [15] Brazil 1 F 25 Pos NR NR
Lasa et al., 2017 [16] Spain 2 M 3 Pos 2.31 Pos
M 12 Pos 24.5 Pos
Totty et al., 2017 [17] United Kingdom 1 M 70 Pos NR NR
Kow et al., 2017 [18] Malaysia 1 M 20 Pos 0.77 NR
Postolova et al., 2017 [19] United States 2 M 60 Pos 0.25 (RV=0.1) NR
F 29 Pos NR NR
Toletone et al., 2018 [3] Italy 1 M 63 Pos 0.04 Pos
Gu et al., 2018 [20] China 1 M 57 Neg* NR NR
SPT, skin prick test; BAT, basophil activation test; NR, not reported; Pos, positive; RV, reference value; Neg, negative.
*The diagnosis was confirmed after the 2nd provocation test.
Mean age was 51 ± 15 years (range, 3–78 years) in agreement with what has already been 
described. The majority of the diagnosis was established through SPT. Twenty-one patients 
performed SPT, 20 were positive. The diagnosis in patient with negative SPT was determined 
by positive provocation test. Fifteen patients performed sIgE and were all positive (mean, 7.12 
kU/L; range, 0.04–30 kU/L). Only 3 performed BAT and were positive.
Our review showed that immediate type I allergic reactions to chlorhexidine are increasing, 
with a mean of 4.8 cases/yr described over the last 5 years, comparing with the 3.25 cases/
yr referred in Odedra et al. [1] review over 20 years. This allows us to admit that true 
incidence of chlorhexidine anaphylaxis is likely to be underestimated in view of its large 
use as a disinfectant. Undervaluation of previous chlorhexidine reactions increases the 
risk of a possibly fatal outcome for the patient after re-exposure in future medical-surgical 
procedures.
A prompt referral to a specialist consultation and detailed allergy study is crucial. Detailed 
history and diagnostic testing allow to confirm the diagnosis of chlorhexidine allergy.
REFERENCES
 1. Odedra KM, Farooque S. Chlorhexidine: an unrecognised cause of anaphylaxis. Postgrad Med J 
2014;90:709-14. 
PUBMED | CROSSREF
 2. Sharp G, Green S, Rose M. Chlorhexidine-induced anaphylaxis in surgical patients: a review of the 
literature. ANZ J Surg 2016;86:237-43. 
PUBMED | CROSSREF
 3. Toletone A, Dini G, Massa E, Bragazzi NL, Pignatti P, Voltolini S, Durando P. Chlorhexidine-induced 
anaphylaxis occurring in the workplace in a health-care worker: case report and review of the literature. 
Med Lav 2018;109:68-76.
PUBMED
 4. Pemberton MN. Allergy to Chlorhexidine. Dent Update 2016;43:272-4. 
PUBMED | CROSSREF
 5. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, 
Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, 
Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres 
M, Trautmann A, Terreehorst I; ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for 
systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 
2013;68:702-12. 
PUBMED | CROSSREF
 6. Egner W, Helbert M, Sargur R, Swallow K, Harper N, Garcez T, Savic S, Savic L, Eren E. Chlorhexidine 
allergy in four specialist allergy centres in the United Kingdom, 2009-13: clinical features and diagnostic 
tests. Clin Exp Immunol 2017;188:380-6. 
PUBMED | CROSSREF
 7. Nakonechna A, Dore P, Dixon T, Khan S, Deacock S, Holding S, Abuzakouk M. Immediate 
hypersensitivity to chlorhexidine is increasingly recognised in the United Kingdom. Allergol 
Immunopathol (Madr) 2014;42:44-9. 
PUBMED | CROSSREF
 8. Weng M, Zhu M, Chen W, Miao C. Life-threatening anaphylactic shock due to chlorhexidine on the 
central venous catheter: a case series. Int J Clin Exp Med 2014;7:5930-6.
PUBMED
 9. Buergi A, Jung B, Padevit C, John H, Ganter MT. Severe anaphylaxis: the secret ingredient. A A Case Rep 
2014;2:34-6. 
PUBMED | CROSSREF
 10. Rutkowski K, Wagner A. Chlorhexidine: a new latex? Eur Urol 2015;68:345-7. 
PUBMED | CROSSREF
5/6https://apallergy.org https://doi.org/10.5415/apallergy.2019.9.e29
Chlorhexidine: a hidden life-threatening allergen
 11. Hong CC, Wang SM, Nather A, Tan JH, Tay SH, Poon KH. Chlorhexidine anaphylaxis masquerading as 
septic shock. Int Arch Allergy Immunol 2015;167:16-20. 
PUBMED | CROSSREF
 12. Stewart M, Lenaghan D. The danger of chlorhexidine in lignocaine gel: a case report of anaphylaxis 
during urinary catheterisation. Australas Med J 2015;8:304-6. 
PUBMED | CROSSREF
 13. Chen P, Huda W, Levy N. Chlorhexidine anaphylaxis: implications for post-resuscitation management. 
Anaesthesia 2016;71:242-3. 
PUBMED | CROSSREF
 14. Wang ML, Chang CT, Huang HH, Yeh YC, Lee TS, Hung KY. Chlorhexidine-related refractory anaphylactic 
shock: a case successfully resuscitated with extracorporeal membrane oxygenation. J Clin Anesth 
2016;34:654-7. 
PUBMED | CROSSREF
 15. Teixeira de Abreu AP, Ribeiro de Oliveira LR, Teixeira de Abreu AF, Ribeiro de Oliveira E, Santos de Melo 
Ireno M, Aarestrup FM, Aarestrup MF, Aarestrup PF. Perioperative anaphylaxis to chlorhexidine during 
surgery and septoplasty. Case Rep Otolaryngol 2017;2017:9605804. 
PUBMED | CROSSREF
 16. Lasa EM, González C, García-Lirio E, Martínez S, Arroabarren E, Gamboa PM. Anaphylaxis caused 
by immediate hypersensitivity to topical chlorhexidine in children. Ann Allergy Asthma Immunol 
2017;118:118-9. 
PUBMED | CROSSREF
 17. Totty J, Forsyth J, Mekako A, Chetter I. Life-threatening intraoperative anaphylaxis as a result of 
chlorhexidine present in Instillagel. BMJ Case Rep 2017;2017:pii: bcr-2017-221443.
PUBMED
 18. Kow RY, Low CL, Ruben JK, Zaharul-Azri MZ, Ng MS. Life-threatening chlorhexidine anaphylaxis: a case 
report. Malays Orthop J 2017;11:72-4. 
PUBMED | CROSSREF
 19. Postolova A, Bradley JT, Parris D, Sherr J, McGhee SA, Hernandez JD. Anaphylaxis to invasive 
chlorhexidine administration despite tolerance of topical chlorhexidine use. J Allergy Clin Immunol Pract 
2018;6:1067-1069.e1. 
PUBMED | CROSSREF
 20. Gu JQ, Liu S, Zhi YX. Provocation Test-confirmed chlorhexidine-induced anaphylaxis in dental procedure. 
Chin Med J (Engl) 2018;131:2893-4.
PUBMED
6/6https://apallergy.org https://doi.org/10.5415/apallergy.2019.9.e29
Chlorhexidine: a hidden life-threatening allergen
